Novel Double Heterozygosity: HBA2: c.70G > A (Hb Chad)/HBB: c.-78A > G and Novel Compound Heterozygosity: HBA2: c.70G > A (Hb Chad)/HBA1: c.84G > T (Hb Hekinan II) Hemoglobinopathy in a Chinese Family.
Chao Ye, Jilin Qing, Yan Wei, Yilian Zhao, Xiaoxing Zhou, Mengru Xie, Zhizhong Chen
{"title":"Novel Double Heterozygosity: <i>HBA2</i>: c.70G > A (Hb Chad)/<i>HBB</i>: c.-78A > G and Novel Compound Heterozygosity: <i>HBA2</i>: c.70G > A (Hb Chad)/<i>HBA1</i>: c.84G > T (Hb Hekinan II) Hemoglobinopathy in a Chinese Family.","authors":"Chao Ye, Jilin Qing, Yan Wei, Yilian Zhao, Xiaoxing Zhou, Mengru Xie, Zhizhong Chen","doi":"10.1080/03630269.2025.2534705","DOIUrl":null,"url":null,"abstract":"<p><p><i>HBA2</i>: c.70G > A (Hb Chad) and <i>HBA1</i>: c.84G > T (Hb Hekinan II) are extremely rare α-globin chain variants, while <i>HBB</i>: c.-78A > G is a relatively common mutation in β-thalassemia. This study aims to identify potential hemoglobin variants in a 12-year-old Chinese boy (proband) and evaluate the presence of thalassemia trait in his parents. We used an automated blood cell analyzer to obtain hematological data, capillary zone electrophoresis to analyze hemoglobin, and sequencing of α-globin and β-globin genes for molecular characterization. The proband exhibited typical thalassemia traits, with hemoglobin electrophoresis suggesting a complex α- and β-chain hemoglobinopathy. Genetic testing revealed that the proband was a double heterozygote for <i>HBA2</i>: c.70G > A (Hb Chad) and <i>HBB</i>: c.-78A > G, while the proband's mother was a compound heterozygote for <i>HBA2</i>: c.70G > A (Hb Chad) and <i>HBA1</i>: c.84G > T (Hb Hekinan II). This study reports for the first time two novel cases of hemoglobinopathy in a Chinese family, involving <i>HBA2</i>: c.70G > A (Hb Chad)/<i>HBB</i>: c.-78A > G and <i>HBA2</i>: c.70G > A (Hb Chad)/<i>HBA1</i>: c.84G > T (Hb Hekinan II).</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"275-280"},"PeriodicalIF":1.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hemoglobin","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03630269.2025.2534705","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/20 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
HBA2: c.70G > A (Hb Chad) and HBA1: c.84G > T (Hb Hekinan II) are extremely rare α-globin chain variants, while HBB: c.-78A > G is a relatively common mutation in β-thalassemia. This study aims to identify potential hemoglobin variants in a 12-year-old Chinese boy (proband) and evaluate the presence of thalassemia trait in his parents. We used an automated blood cell analyzer to obtain hematological data, capillary zone electrophoresis to analyze hemoglobin, and sequencing of α-globin and β-globin genes for molecular characterization. The proband exhibited typical thalassemia traits, with hemoglobin electrophoresis suggesting a complex α- and β-chain hemoglobinopathy. Genetic testing revealed that the proband was a double heterozygote for HBA2: c.70G > A (Hb Chad) and HBB: c.-78A > G, while the proband's mother was a compound heterozygote for HBA2: c.70G > A (Hb Chad) and HBA1: c.84G > T (Hb Hekinan II). This study reports for the first time two novel cases of hemoglobinopathy in a Chinese family, involving HBA2: c.70G > A (Hb Chad)/HBB: c.-78A > G and HBA2: c.70G > A (Hb Chad)/HBA1: c.84G > T (Hb Hekinan II).
期刊介绍:
Hemoglobin is a journal in the English language for the communication of research and information concerning hemoglobin in humans and other species. Hemoglobin publishes articles, reviews, points of view
The journal covers topics such as:
structure, function, genetics and evolution of hemoglobins
biochemical and biophysical properties of hemoglobin molecules
characterization of hemoglobin disorders (variants and thalassemias),
consequences and treatment of hemoglobin disorders
epidemiology and prevention of hemoglobin disorders (neo-natal and adult screening)
modulating factors
methodology used for diagnosis of hemoglobin disorders